Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Nanomedicine. 2012 Apr 26;9(1):122–129. doi: 10.1016/j.nano.2012.03.008

Table 1. Pharmacokinetic parameters of phrGFP siRNA following IV administration of HSA-LNPs-siRNA to ICR mice at a dose of 1 mg/kg.

Group siRNA alone HSA-LNPs-siRNA
AUC (μg·minr/ml) 84.6±18.7 341.5±29.5
t½(α) (min) 11.5±4.0 5.8±0.5
t½(β) (min) - 150.8±25.7
CL (ml/min/kg) 11.8±2.6 2.9±0.2
MRT (0-24min) 16.6±5.8 192.8±28.5

Data represents the mean±SD (n=3).